{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:02:36Z","timestamp":1648753356519},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:p>The pegylated liposomal doxorubicin (PLD) was introduced clinically in the 1990s and won FDA approvals for the treatment of Kaposi's sarcoma (1995) and ovarian cancer (2000). At present, it seems prudent to engage patients in a discussion of risks (of a secondary cancer) versus benefits.<\/jats:p>","DOI":"10.1634\/theoncologist.2013-0021","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T03:27:13Z","timestamp":1363231633000},"page":"245-247","source":"Crossref","is-referenced-by-count":5,"title":["Squamous Cell Carcinomas of the Tongue and Oral Cavity as Secondary Malignancies: What Factors Are Implicated?"],"prefix":"10.1093","volume":"18","author":[{"given":"Franco","family":"Muggia","sequence":"first","affiliation":[{"name":"New York University Cancer Institute, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"2021122308322441300_B1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0959-8049(01)00053-3","article-title":"Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin","volume":"37","author":"Hengge","year":"2001","journal-title":"Eur J Cancer"},{"key":"2021122308322441300_B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/589865","article-title":"Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin","volume":"47","author":"Mart\u00edn-Carbonero","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021122308322441300_B3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/annonc\/mdl484","article-title":"Pegylated liposomal doxorubicin HCL (PLD; Caelyx\/Doxil): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer","volume":"18","author":"Andreopoulou","year":"2007","journal-title":"Ann Oncol"},{"key":"2021122308322441300_B4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jnci\/djq484","article-title":"Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer","volume":"103","author":"Muggia","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2021122308322441300_B5","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/annonc\/mds172","article-title":"Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer","volume":"23","author":"Verschraegen","year":"2012","journal-title":"Ann Oncol"},{"issue":"suppl","key":"2021122308322441300_B6","doi-asserted-by":"crossref","first-page":"5557a","DOI":"10.1200\/jco.2011.29.15_suppl.5557","article-title":"Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer","volume":"15","author":"Cannon","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122308322441300_B7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1634\/theoncologist.2011-0216","article-title":"Squamous cell carcinoma of the oral cavity in nonsmoking women: A new and unusual complication of chemotherapy for recurrent ovarian cancer","volume":"17","author":"Cannon","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308322441300_B8","article-title":"Does long-term treatment with Doxil predispose patients to oral cancer?","author":"Ben-David","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"2021122308322441300_B9","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1200\/JCO.2005.05.029","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide","volume":"23","author":"Praga","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122308322441300_B10","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2003.07.160","article-title":"Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group","volume":"21","author":"Josting","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122308322441300_B11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00043426-200102000-00008","article-title":"Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group","volume":"23","author":"Shearer","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122308322441300_B12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1023\/A:1013148730966","article-title":"Second malignancies after ewing tumor treatment in 690 patients from a cooperative German\/Austrian\/Dutch study","volume":"12","author":"Paulussen","year":"2001","journal-title":"Ann Oncol"},{"key":"2021122308322441300_B13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-07-235051","article-title":"Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia","volume":"115","author":"Mays","year":"2010","journal-title":"Blood"},{"key":"2021122308322441300_B14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa042715","article-title":"DNA topoisomerase II in therapy-related acute promyelocytic leukemia","volume":"352","author":"Mistry","year":"2005","journal-title":"N Engl J Med"},{"key":"2021122308322441300_B15","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1634\/theoncologist.2011-0280","article-title":"Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicin","volume":"17","author":"Bonomi","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308322441300_B16","first-page":"243","article-title":"Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes","volume":"7","author":"Harrington","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2021122308322441300_B17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1634\/theoncologist.2012-0358","article-title":"Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer","volume":"17","author":"Matsuo","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308322441300_B18","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/1535-7163.MCT-11-0272","article-title":"BRCA mutation status as determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin","volume":"10","author":"Safra","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"2021122308322441300_B19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1634\/theoncologist.2012-0429","article-title":"Aggressive squamous cell carcinoma of the oral tongue in a woman with metastatic giant cell tumor treated with pegylated liposomal doxorubicin","volume":"17","author":"Gu","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308322441300_B20","first-page":"673","article-title":"The role of the tumor suppressor RUNX3 in giant cell tumor of the bone","volume":"40","author":"Han","year":"2012","journal-title":"Int J Oncol"},{"key":"2021122308322441300_B21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0147-0272(87)80008-9","article-title":"Malignancies in the acquired immunodeficiency syndrome","volume":"11","author":"Levine","year":"1987","journal-title":"Curr Probl Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2013-0021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2013-0021","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/3\/245\/41856205\/oncolo_18_3_245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/3\/245\/41856205\/oncolo_18_3_245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T22:58:35Z","timestamp":1640300315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/3\/245\/6410188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,13]]},"published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2013-0021","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3,1]]},"published":{"date-parts":[[2013,3,1]]}}}